Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 30 (8) , 695-706
- https://doi.org/10.1016/j.ctrv.2004.04.003
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Estrogen and cognitive aging in womenTrends in Pharmacological Sciences, 2002
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Comparison of Effects of Tamoxifen and Toremifene on Bone Biochemistry and Bone Mineral Density in Postmenopausal Breast Cancer PatientsJournal of Clinical Endocrinology & Metabolism, 1998
- The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistanceBritish Journal of Cancer, 1997
- Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.Journal of Clinical Oncology, 1996
- Comparison between the Effects of Tamoxifen and Toremifene on the Uterus in Postmenopausal Breast Cancer PatientsGynecologic Oncology, 1995
- Preclinical data for DroloxifeneCancer Letters, 1994
- Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *JNCI Journal of the National Cancer Institute, 1994
- Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levelsBreast Cancer Research and Treatment, 1988
- Influence of Synthetic Oestrogens on Advanced Malignant DiseaseBMJ, 1944